Maintaining Brain Resilience with prevents disease in rat and mouse models of Alzheimer’s disease and restores brain health and cognition in chronic traumatic brain injury
Andrew A Pieper · 2025
Read Maintaining Brain Resilience with prevents disease in rat and mouse models of Alzheimer’s disease and restores brain health and cognition in chronic traumatic brain injury by Andrew A Pieper (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709960.txt.
Description
Andrew A Pieper reports a 2025 conference abstract on a drug family that may keep the brain resilient. The drugs, called P7C3 compounds, restore a key energy balance inside cells. Pieper tested early dosing in mouse and rat models of Alzheimer's disease, and later dosing in mice with long-term brain injury.
Early dosing in the disease models blocked plaque buildup, tau changes, barrier damage, inflammation, and memory loss. In injured mice, late dosing repaired the blood-brain barrier and fully restored thinking a year after injury. The same drugs also shielded human barrier cells from stress in lab tests. The work supports resilience as a treatment goal.
Catalog record
| CREATOR | Andrew A Pieper |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |